Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,952 | 1,356 | 9,933 | -19,431 | -14,256 |
| Depreciation Amortization | 366 | 250 | 115 | 220 | 132 |
| Accounts payable and accrued liabilities | -2,335 | -1,992 | -1,697 | -865 | -16 |
| Other Working Capital | -12,521 | -5,608 | -2,528 | 140 | 1,313 |
| Other Operating Activity | -21,374 | -22,320 | -23,285 | 1,535 | 173 |
| Operating Cash Flow | $-38,816 | $-28,314 | $-17,462 | $-18,401 | $-12,654 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,106 | 10,044 | 5,700 | N/A | N/A |
| PPE Investments | 125 | 93 | 47 | -1,339 | -1,238 |
| Net Acquisitions | 30,392 | 30,392 | 30,392 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -1,186 | -564 |
| Investing Cash Flow | $45,623 | $40,529 | $36,139 | $-2,525 | $-1,802 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 12,750 | 4,000 |
| Debt Repayment | -4,000 | -966 | -514 | N/A | N/A |
| Common Stock Issued | 95 | 25 | 17 | 54 | 51 |
| Financing Cash Flow | $-3,905 | $-941 | $-497 | $12,804 | $4,051 |
| Beginning Cash Position | 7,740 | 7,740 | 7,740 | 15,862 | 15,862 |
| End Cash Position | 10,642 | 19,014 | 25,920 | 7,740 | 5,457 |
| Net Cash Flow | $2,902 | $11,274 | $18,180 | $-8,122 | $-10,405 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,816 | -28,314 | -17,462 | -18,401 | -12,654 |
| Capital Expenditure | -185 | -183 | -155 | -1,344 | -1,243 |
| Free Cash Flow | -39,001 | -28,497 | -17,617 | -19,745 | -13,897 |